for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bruker Corporation

BRKR.OQ

Latest Trade

43.88USD

Change

0.36(+0.83%)

Volume

69,115

Today's Range

43.77

 - 

44.24

52 Week Range

26.11

 - 

51.35

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
43.52
Open
43.90
Volume
69,115
3M AVG Volume
18.12
Today's High
44.24
Today's Low
43.77
52 Week High
51.35
52 Week Low
26.11
Shares Out (MIL)
154.67
Market Cap (MIL)
6,731.06
Forward P/E
27.00
Dividend (Yield %)
0.37

Next Event

Q3 2019 Bruker Corp Earnings Release

Latest Developments

More

Bruker Announces Acquisition Of Magnettech's EPR Business

Bruker Posts Q2 EPS Of $0.23

Bruker Comments On Block Trade Transaction

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Bruker Corporation

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Industry

Scientific & Technical Instr.

Contact Info

40 MANNING RD

+1.978.6633660

https://www.bruker.com/

Executive Leadership

Frank H. Laukien

Chairman of the Board, President, Chief Executive Officer

Gerald N. Herman

Chief Financial Officer

Falko Busse

President, Bruker BioSpin Group

Burkhard Prause

President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc

Juergen Srega

President of Bruker CALID Group and Bruker Daltonics Division

Key Stats

2.00 mean rating - 12 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

1.6K

2017

1.8K

2018

1.9K

2019(E)

2.0K
EPS (USD)

2016

1.190

2017

1.210

2018

1.400

2019(E)

1.612
Price To Earnings (TTM)
36.29
Price To Sales (TTM)
3.41
Price To Book (MRQ)
7.82
Price To Cash Flow (TTM)
25.82
Total Debt To Equity (MRQ)
57.41
LT Debt To Equity (MRQ)
57.38
Return on Investment (TTM)
12.90
Return on Equity (TTM)
9.13

Latest News

Latest News

BRIEF-Bruker Corp Q1 GAAP Earnings Per Share $0.17

* GUIDANCE FOR FISCAL YEAR 2018 REVENUE GROWTH, NON-GAAP OPERATING MARGIN EXPANSION AND NON-GAAP EPS IS UNCHANGED

BRIEF-Bruker Appoints Falko Busse As President Of The Bruker BioSpin Group

* BRUKER APPOINTS FALKO BUSSE AS PRESIDENT OF THE BRUKER BIOSPIN GROUP Source text for Eikon: Further company coverage:

BRIEF-Bruker Acquires Nanoir Company Anasys Instruments

* BRUKER CORP - FINANCIAL DETAILS OF TRANSACTION WERE NOT DISCLOSED. Source text for Eikon: Further company coverage:

BRIEF-Bruker Appoints Gerald Herman As Interim CFO

* BRUKER APPOINTS GERALD HERMAN AS INTERIM CHIEF FINANCIAL OFFICER

BRIEF-Bruker Corp Files For Non-Timely 10-K

* BRUKER CORP SAYS CO IS IN PROCESS OF ANALYZING TIMING OF CERTAIN SALES TRANSACTIONS WITHIN DIVISION IN 2014, 2015 AND 2016

BRIEF-Bruker Corp Buys High-Speed Qcl Infrared Microscopy Company Irm

* BRUKER ACQUIRES HIGH-SPEED QCL INFRARED MICROSCOPY COMPANY IRM

BRIEF-Bruker Reports Q4 GAAP Loss Per Share $0.02

* BRUKER REPORTS FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS

BRIEF-Bruker reports third quarter 2017 financial results

* Q3 revenue $435.6 million versus I/B/E/S view $414.6 million

BRIEF-Bruker acquires Merlin to add selected antibiotic resistance and susceptibility testing to its Maldi Biotyper platform

* Bruker announces acquisition of Merlin to add selected antibiotic resistance and susceptibility testing to its Maldi Biotyper® microbial identification platform

BRIEF-Bruker acquires XGLab with X-ray detection technologies, XRF instruments

* Bruker acquires company XGLab with unique X-ray detection technologies and XRF instruments for art & conservation markets

BRIEF-Bruker Q2 non-gaap earnings per share $0.23

* Q2 revenue $414.9 million versus I/B/E/S view $385.5 million

BRIEF-Bruker announces US FDA clearance of expanded 3rd claim for Maldi Biotyper

* Bruker announces US FDA clearance of expanded 3rd claim for Maldi Biotyper Source text for Eikon: Further company coverage:

BRIEF-Bruker says Chris Ingen inteds to retire from co's board

* Bruker Corp - on June 22, 2017, Chris Van Ingen informed co of his intention to retire from company's board of directors, effective June 30

BRIEF-Bruker announces new $225 mln share repurchase program and qtrly dividend

* Bruker announces new $225 million share repurchase program and quarterly dividend

BRIEF-Bruker acquires emerging light sheet microscopy company Luxendo

* Bruker acquires emerging light sheet microscopy company Luxendo Source text for Eikon: Further company coverage:

BRIEF-Alcami invests in Bruker's D8 Discover HTS System for high-throughput X-Ray diffraction screening in pharmaceutical formulation development

* Alcami invests in Bruker's D8 Discover HTS System for high-throughput X-Ray diffraction screening in pharmaceutical formulation development Source text for Eikon: Further company coverage:

BRIEF-Bruker reports Q4 GAAP EPS $0.43

* Bruker reports fourth quarter and fiscal year 2016 financial results

BRIEF-Albany Molecular enters alliance with Bruker Daltonics, Highres Biosolutions

* Albany Molecular Research says has entered an alliance with Bruker Daltonics and Highres Biosolutions

BRIEF-Bruker acquires Nanoindenting Leader Hysitron

* Bruker announces acquisition of Nanoindenting Leader Hysitron

BRIEF-Bruker reports third quarter 2016 financial results

* Bruker Corp says now expects to increase its 2016 non-gaap operating margin by 100 basis points or more year-over-year

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up